Syntr Health Technologies, Inc
Microfluidic tissue dissociation device (Syntrfuge) that rapidly converts tumor tissue into viable single cells for analysis
- Sector
- Medtech
- Headquarters
- IRVINE, CA
- Founded
- 2018
- Latest Form D
- $795K, Sep 2022
- Total capital
- $4.3M
- Federal grants
- $2.9M
- 7 awards · 2017–2025
- Rank in peer group#12 of 542
- Private capital raised
- $1.5M
- 2 Form D · last Sep 2022
- 50 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing$1.1M
- Federal grantHealth and Human S · Phase I · Accelerating Bioengineering Approaches for Increasing Access to New Solutions Targeting Breast Cancer Reconstructive Surgery$357K
- Federal grantHealth and Human S · Phase I · Rapid and Automated Dissociation of Tumor Tissue for Single Cell Diagnostics$407K
- Federal grantHealth and Human S · Phase I · Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing$135K
- Federal grantHealth and Human S · Phase I · Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing$306K
- Private capital raisedForm D · SEC · 2nd filing$795K
- Private capital raisedForm D · SEC · 1st filing$681K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · Mechanical Activation of Adipose Derived Stem Cells for the Treatment of Diabetic Foot Ulcers Using a Novel CD Microfluidic Device$300K
- Federal grantHealth and Human S · Phase I · Mechanical Activation of Adipose-Derived Stem Cells for the Treatment of Diabetic Foot Ulcers Using a Novel CD-Microfluidic Device$300K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
28months
from Syntr Health Technologies, Inc’s first federal award to its first private round.
- First federal award · Sep 2017
- Health and Human S · $300K
- First Form D · Jan 2020
- $681K · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 542 peers
Line = medianMedtech · Device
- Federal grants#12 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Ahmed ZobiResearcherExecutive Officer, DirectorLinked by $300K in grants as PI
- Dane ShacklefordDirectorNamed in SEC Form D filings
- Hugo SalasDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingMethod And Device For Processing Tissues And Cells By Rotating Microfluidic Chips Mounted On A Support PlateUSPTOApplication 17924962
- PendingDevices And Methods For Promoting Stability And Efficacy Of A Biologic CompositionUSPTOApplication PCTUS2025054334
- PendingDevices And Methods For Promoting Stability And Efficacy Of A Biologic CompositionUSPTOApplication 63718166
Show all 5 patent records
- Method And Device For Processing Tissues And Cells By Rotating Microfluidic Chips Mounted On A Support PlateSep 26, 2024 · Application 17924962Pending
- Devices And Methods For Promoting Stability And Efficacy Of A Biologic CompositionApplication PCTUS2025054334Pending
- Devices And Methods For Promoting Stability And Efficacy Of A Biologic CompositionApplication 63718166Pending
- Method And Device For Processing Tissues And CellsApplication PCTUS2021031620Pending
- Method And Device For Processing Tissues And CellsApplication 63023060Pending
Related companies, and why
- Rochal Industries, LLCSimilar federal contract value in Medtech · null in contracts
- PHENIX MEDICAL, LLCSimilar federal contract value in Medtech · null in contracts
- SPEECH TECHNOLOGY/APPLIED RESEARCH CORP.Similar federal contract value in Medtech · null in contracts
- Vektor Medical, Inc.Similar federal contract value in Medtech · null in contracts
- COGWEAR LLCSimilar federal contract value in Medtech · null in contracts
- I-O Urology CorpSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .